- Home
- AVIR vs WRN Comparison
AVIR vs WRN Comparison
Compare AVIR & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- WRN
- Stock Information
- Founded
- AVIR 2012
- WRN 2006
- Country
- AVIR United States
- WRN Canada
- Employees
- AVIR 56
- WRN N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- WRN Metal Mining
- Sector
- AVIR Health Care
- WRN Basic Materials
- Exchange
- AVIR Nasdaq
- WRN Nasdaq
- Market Cap
- AVIR 277.8M
- WRN 248.0M
- IPO Year
- AVIR 2020
- WRN N/A
- Fundamental
- Price
- AVIR $3.42
- WRN $1.27
- Analyst Decision
- AVIR Hold
- WRN Strong Buy
- Analyst Count
- AVIR 1
- WRN 1
- Target Price
- AVIR $6.00
- WRN $4.00
- AVG Volume (30 Days)
- AVIR 350.2K
- WRN 280.0K
- Earning Date
- AVIR 08-07-2025
- WRN 08-08-2025
- Dividend Yield
- AVIR N/A
- WRN N/A
- EPS Growth
- AVIR N/A
- WRN N/A
- EPS
- AVIR N/A
- WRN N/A
- Revenue
- AVIR N/A
- WRN N/A
- Revenue This Year
- AVIR N/A
- WRN N/A
- Revenue Next Year
- AVIR N/A
- WRN N/A
- P/E Ratio
- AVIR N/A
- WRN N/A
- Revenue Growth
- AVIR N/A
- WRN N/A
- 52 Week Low
- AVIR $2.46
- WRN $0.90
- 52 Week High
- AVIR $4.15
- WRN $1.42
- Technical
- Relative Strength Index (RSI)
- AVIR 48.09
- WRN 45.64
- Support Level
- AVIR $3.44
- WRN $1.20
- Resistance Level
- AVIR $3.60
- WRN $1.30
- Average True Range (ATR)
- AVIR 0.16
- WRN 0.04
- MACD
- AVIR -0.02
- WRN -0.00
- Stochastic Oscillator
- AVIR 25.12
- WRN 36.31
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).